Skip to main content

Table 2 Demographic and clinical characteristics of HIV-1-infected

From: Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients

Parameters

All population

Female

Male

pvalue

Mean ± SD

Median with IQR

n(n%)

Mean ± SD

Median with IQR

n(n%)

Mean ± SD

Median with IQR

n(n%)

Age (years)

45 ± 8

47(44–52)

-

49 ± 5

51(45–52)

-

43 ± 9

46 (37–48)

-

0.067

Gender (female)

-

-

15 (50)

-

-

-

-

-

-

-

Smokers

-

-

17 (57)

-

-

6 (40)

-

-

11 (73)

0.762

BMI (Kg/m2)

23 ± 3

23 (21–25)

 

22 ± 4

21(19–24)

 

23 ± 2

24(22–25)

-

0.373

Race (Caucasian)

-

-

29 (97)

-

 

14 (93)

-

-

15 (100)

0.987

Years on ART (years)

12 ± 9

11 (5–19)

-

17 ± 6

15(11–22)

-

9 ± 9

5(1–15)

-

0.012

Years HIV diagnosis (years)

12 ± 9

11(5–19)

-

17 ± 6

15(11–22)

-

9 ± 9

5(1–15)

-

0.014

CD4+ actual (cells/mm3)

744 ± 299

708 (623–886)

-

790 ± 275

789 (692–886)

-

718 ± 317

667 (623–825)

-

0.560

CD4+ (%)

33 ± 11

34 (30–38)

-

38 ± 5

36 (30–38)

-

30 ± 12

32 (24–37)

-

0.032

CD4+ nadir (cells/mm3)

283 ± 223

301 (74–382)

-

182 ± 144

163 (74–278)

-

321 ± 239

322 (109–522)

 

0.117

HCV infection

-

-

3 (10)

-

-

1 (7)

-

-

2 (13)

0.922

HIV-RNA actual (copies/mL)

< 37

-

-

< 37

-

-

<37

-

-

1.000

  1. SD standard deviation, BMI body mass index, ART antiretroviral therapy